Want to see TSE:GREY full AI Analyst Report?
GREY Stock Chart & Stats
C$0.45
>-C$0.01(-1.27%)
At close: 4:00 PM EDT
C$0.45
>-C$0.01(-1.27%)
Day’s Range― - ―
52-Week RangeC$0.34 - C$0.90
Previous CloseN/A
Volume4.50K
Average Volume (3M)9.68K
Market Cap
C$3.30M
Enterprise ValueC$3.70
Total Cash (Recent Filing)C$210.03K
Total Debt (Recent Filing)C$0.00
Price to Earnings (P/E)―
Beta0.15
Next Earnings
Dec 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.62
Shares Outstanding8,923,237
10 Day Avg. Volume13,474
30 Day Avg. Volume9,680
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.77
Price to Sales (P/S)0.00
P/FCF Ratio-1.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)5.02
Revenue Forecast (FY)C$45.78M
Bulls Say, Bears Say
Bulls Say
Debt-Free Balance SheetThe absence of debt limits interest obligations and reduces refinancing pressure while the company develops its products. This gives management greater flexibility to allocate available capital toward operations, although ongoing losses still make overall financial strength limited.
Narrowing Net LossesMeaningful loss reduction indicates that operating performance has improved from earlier periods, which could support a more sustainable business model if the trend continues. However, the company remains unprofitable, so this is an improvement in trajectory rather than established earnings strength.
Clinically Oriented VR PlatformA focused portfolio of VR-based therapeutic and training applications gives Grey Matters Health a defined position within digital health. Its healthcare and wellness orientation may support specialized product relevance, while the stated applications provide a platform for future commercialization.
Bears Say
No Revenue BaseZero reported revenue means the business has not yet demonstrated commercial traction or validated recurring demand at scale. Without a revenue base, future growth remains dependent on converting its products and applications into paying healthcare or wellness activity.
Persistent UnprofitabilityContinued negative gross profit and operating losses show that current activity is not yet covering the cost of the business. This weakens earnings visibility and leaves the company dependent on future revenue growth or further expense reductions to establish a viable economic model.
Ongoing Cash BurnPersistent negative operating and free cash flow indicates that the company is not self-funding its activities. Even though burn has improved, continued cash usage may require external capital before revenue scale or materially lower expenses can support ongoing operations.
Grey Matters Health News
GREY FAQ
What was Grey Matters Health’s price range in the past 12 months?
Grey Matters Health lowest stock price was C$0.34 and its highest was C$0.90 in the past 12 months.
What is Grey Matters Health’s market cap?
Grey Matters Health’s market cap is C$3.30M.
When is Grey Matters Health’s upcoming earnings report date?
Grey Matters Health’s upcoming earnings report date is Dec 18, 2026 which is in 77 days.
How were Grey Matters Health’s earnings last quarter?
Grey Matters Health released its earnings results on Jul 29, 2026. The company reported -C$0.13 earnings per share for the quarter.
Is Grey Matters Health overvalued?
According to Wall Street analysts Grey Matters Health’s price is currently Overvalued.
Does Grey Matters Health pay dividends?
Grey Matters Health does not currently pay dividends.
What is Grey Matters Health’s EPS estimate?
Grey Matters Health’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Grey Matters Health have?
Grey Matters Health has 8,923,237 shares outstanding.
What happened to Grey Matters Health’s price movement after its last earnings report?
Grey Matters Health reported an EPS of -C$0.13 in its last earnings report. Following the earnings report the stock price went down -2.667%.
Which hedge fund is a major shareholder of Grey Matters Health?
Currently, no hedge funds are holding shares in TSE:GREY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Grey Matters Health
Grey Matters Health Inc. operates as a clinical stage pharmaceutical development company in Canada and Australia. The company focuses on developing the therapeutic drugs in the areas of non-alcoholic steatohepatitis, liver disease, chronic kidney disease, and stroke program. Its pipeline includes repirinast for the treatment of chronic kidney disease; and N,N-Dimethyltryptamine for the treatment of strokes and traumatic brain injuries. The company was formerly known as Algernon Health Inc. and changed its name to Grey Matters Health Inc. in April 2026. Algernon Health Inc. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Technical Analysis
Appili Therapeutics Inc Class A
―
Rakovina Therapeutics Inc
―
Universal Ibogaine Inc
―
Mindbio Therapeutics Corp.
―
Neural Therapeutics Inc.
―